PTC THERAPEUTICS, INC. - Common Stock (PTCT)

CUSIP: 69366J200

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / Common Stock
Shares outstanding
80,855,533
Total 13F shares
28,567,042
Share change
-1,878,588
Total reported value
$202,093,852
Put/Call ratio
52%
Price per share
$7.02
Number of holders
113
Value change
-$12,310,362
Number of buys
57
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2016

As of 30 Jun 2016, PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,567,042 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Camber Capital Management LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, TOCQUEVILLE ASSET MANAGEMENT L.P., PICTET ASSET MANAGEMENT LTD, BlackRock Fund Advisors, BB BIOTECH AG, FMR LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 113 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.